
A synthetic zzso zzso was administered zzso to five patients with either relapsed or zzso acute zzso leukemia zzso or zzso syndrome zzso Patients received a 10-day continuous intravenous infusion of this compound, which is complementary to zzso zzso No major toxicity attributable to a dose of zzso zzso was zzso A range of approximately 9 to zzso of the administered dose was recovered in the urine as intact zzso zzso of zzso cells recovered from bone zzso and peripheral blood at intervals before, zzso and after treatment reveals no enhanced growth potential following zzso zzso zzso a zzso zzso complementary to zzso zzso can be administered at this dose level to humans without major zzso Higher doses need to be evaluated for toxicity and potential clinical zzso 

